CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 480 enrolled
Drug / intervention
4 mL injection of AMPION™ +1 morebiological
Likely dose
4 mL injection of AMPION™from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02556710
NCT02556710Phase 3Completed
CompareCT.gov

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluated the Efficacy and Safety of an Intra-Articular Injection of AMPION™ in Adults With Pain Due to Osteoarthritis of the Knee

Ampio Pharmaceuticals. Inc.·interventional·Posted Sep 22, 2015·Updated Aug 9, 2022

In Brief

A Phase 3 clinical trial evaluating 4 mL injection of AMPION™ and 4 mL injection of Placebo for Osteoarthritis of the Knee. Completed, enrolled 480 participants across 1 site.

Detailed Summary

This study will evaluate the efficacy and safety of an intra-articular injection of AMPION™ in adults with pain due to osteoarthritis of the knee

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis of the Knee
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 22, 2015
Enrollment StartSep 1, 2015
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 10.8 years ago

Interventions

4 mL injection of AMPION™biological

4 mL Injection of Ampion

4 mL injection of Placebodrug

4 mL Injection of Placebo